General description
A fluoroquinolone antibacterial compound that displays antitumor properties. Shown to bind to the miRNA biosynthesis protein TAR RNA-binding protein 2 (TRBP; Kd = 12.56 µM), enhance RNAi and stimulate miRNA expression. Specifically induces cell-cycle arrest and apoptosis in a panel of 12-cancer cells (EC50 of 124 µM in HCT-116 cells) and suppresses tumor growth in a xenograft mouse model (10 mg/kg, i.p.).
Legal Information
CALBIOCHEM is a registered trademark of Merck KGaA, Darmstadt, Germany
Other Notes
Melo, S., et al. 2011. Proc. Natl. Acad. Sci. USA108, 4394.Zhang, Q., et al. 2008. Cell Res.18, 1077.Shan, G., et al. 2008. Nat. Biotechnol.26, 933.
Packaging
250 mg in Glass bottle
Packaged under inert gas
Reconstitution
Following reconstitution, aliquot and freeze (-20°C). Stock solutions are stable for up to 1 year at -20°C.
Warning
Toxicity: Standard Handling (A)
This product has met the following criteria: